The H100 group, Swedish Health-Tech Study, received 144.8 BTC as part of an agreement linked to its convertible loan agreement, according to a press release from the company issued on Monday. With this last transaction, the company based in Stockholm now holds a total of 169.2 BTC in its budget.
144.8 BTC was transferred as part of the first four segments of the H100 loan agreement, which has been well accepted by the investors so far. H100 declared in the press release, “Group H100 AB (” Group H100 “or” Company “) received 144.8 BTC today as part of the proceeds from tranches from 1 to 4 based on its convertible loan agreements previously announced”.
This follows the recent reference that the Blockstream CEO Adam Back has undertaken to drive a financing initiative of 750 million Kronor (~ $ 79 million) for H100, anchored by an injection of 150 million krona in Tranche 6. The loan, structured for speed and efficiency of costs, was evaluated at 6.38 Kronor per action-a-premium 33% at the market-
The structure of the loan includes the flexibility of settlement, both in cash and in Bitcoin, which allows the counterparties to opt for the delivery of BTC, reducing the Fiat friction and the row with the long -term treasure prospects of the company.
“Unexpectedly, given the strong welcome, tranche 1-4 have quickly become cash,” Back said to Coindesk. “I expected [H100] It would convert them over time when they reached Money status. ”
This financing approach allows H100 to bypass traditional rights issues during capital in a flexible way. Tranche 7 and 8 are on the bridge, with space for the increases in size depending on the appetite of the market.
This also reflects the evolving financial strategy of H100. While the basic operations of the company remain concentrated on health services and longevity guided by the AI, its growing position of Bitcoin is remodeling the way in which the capital is collected, archived and distributed. Starting now, the company’s BTC participations are at 169.2 BTC, only 24.41 BTC before the latter execution of tranches.
The H100 stock has increased by 22% on Monday in response to developments.
While the company continues the negotiations for future tranches and explores the adoption of BTC as a financial dorsal spine, it is univocally positioned to the intersection between health technology and decentralized finance.